Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
Zacks Investment Research on MSN2d
DexCom CGM Sensor Sales to Continue Despite FDA Warning LetterDexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
The announcement came after a quarter where DexCom reported a 7% increase in sales, though net income declined significantly alongside a reduction in earnings per share. During the past quarter ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
EST DexCom (DXCM) falls 7% to $71.99 after receiving warning letter from FDADiscover the Best Stocks and Maximize Your Portfolio: See ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
The FDA cited issues with DexCom's response to prior inspection findings, known as Form 483 observations. The inspections took place at the San Diego facility between October 21 and November 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback